Sodium Bicarbonate Antacid Tablet
FDA Label NDC 71610-669

17 label sections · Submitted to the FDA by Aphena Pharma Solutions - Tennessee, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Aphena Pharma Solutions - Tennessee, Llc for the product Sodium Bicarbonate Antacid (NDC 71610-669). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, purpose, uses, warnings, otc - ask doctor, otc - ask doctor/pharmacist, otc - stop use, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Repackaging Information

Please reference the HOW SUPPLIED section listed above for a description of individual drug products listed below. This drug product has been received by Aphena Pharma Solutions - Tennessee, LLC in a manufacturer or distributor packaged configuration and repackaged in full compliance with all applicable cGMP regulations. The package configurations available from Aphena are listed below:

10gr (650mg)
NDC 71610-669-53, Bottles of 60 Tablets
NDC 71610-669-60, Bottles of 90 Tablets
NDC 71610-669-80, Bottles of 180 Tablets


Store between 20°-25°C (68°-77°F). See USP Controlled Room Temperature. Dispense in a tight light-resistant container as defined by USP. Keep this and all drugs out of the reach of children.

Repackaged by:

Aphena (Aphena)

Aphena (Aphena)



Cookeville, TN 38506

20260323BSC

Principal Display Panel - 650 Mg

NDC 71610-669 - Sodium Bicarbonate 10gr (650 mg) Tablets

Label (71610 0669 53)

Label (71610 0669 53)

* Please review the disclaimer below.